Syschem (India) Ltd.

BSE: SYSCHEM · Pharmaceuticals · sector

₹33.22BSE close 2026-10-26

Key numbers

Market cap₹178 cr

Price₹33.22

52w high / low₹61 / ₹29

P/E15.8xSector median 27.9x

P/B1.5xSector median 2.9x

Book value₹22.8

Dividend yield–Sector median 0.48%

ROE5.8%Sector median 11.7%

ROCE11.7%Sector median 12.3%

OPM2.9%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA8.8xSector median 18.6x

Interest cover5.3x

Current ratio1.34x

Sales growth 3y+71.2%Sector median +9.6%

Profit growth 3y+34.3%Sector median +13.3%

PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹9 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 5.3x in the last 12 months.
Net loss in 1 of the last 6 quarters.
Other income was 1% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹33.22 on 2026-10-26: -45.5% from the 52-week high, +15.3% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹59.37 · low ₹29.70

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	139	127	118	162	248	126
EBITDA	2	2	3	6	9	1
OPM %	1.4%	1.9%	2.8%	3.7%	3.8%	0.4%
Other income	0	0	0	0	0	0
Net profit	0	2	2	4	2	-2
EPS (₹)	0.11	0.38	0.44	0.96	0.40	0.31
Revenue YoY					+79.0%	-0.6%
Profit YoY					+278.3%	-200.0%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	66	130	233	386	655	654
EBITDA	1	9	7	4	21	19
Net profit	-2	5	2	0	11	6
EPS (₹)	-0.76	–	0.78	0.12	2.50	2.11
Revenue growth		+98.7%	+79.1%	+65.4%	+69.5%	–
Profit growth		–	-53.9%	-77.9%	+2,276.1%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+71.2%	–	–
Net profit	+34.3%	–	–
EPS	–	–	–
Share price	–	-7.9% (2y)	-40.6%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	91	122
Borrowings	0	0
Cash & equivalents	90	9
Total assets	217	292
Fixed assets	53	68
Capital work in progress	0	–
Investments	0	0
Receivables	2	144
Inventory	68	58
Payables	121	160

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-10	8
Cash from investing	-22	-20
Cash from financing	34	18
Capex	22	0
Free cash flow	-32	8

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	0.5%	8.9%
ROCE %	1.2%	13.9%
Debtor days	2	81
Inventory days	81	41
Payable days	143	112
Cash conversion cycle (days)	-60	10
Working capital days	35	31

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
SYSCHEM	₹178 cr	15.8x	1.5x	5.8%	11.7%	2.9%	+71.2%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	SYSCHEM
BSE code	531173
ISIN	INE121D01036
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.